Palliative Care in Heart Failure
- 445 Downloads
Purpose of review
This review illustrates the dynamic role of palliative care in heart failure management and encapsulates the commonly utilized pharmacologic and non-pharmacologic therapeutic strategies for symptom palliation in heart failure. In addition, we provide our experience regarding patient care issues common to the domain of heart failure and palliative medicine which are commonly encountered by heart failure teams.
Addition of palliative care to conventional heart failure management plan results in improvement in quality of life, anxiety, depression, and spiritual well-being among patients.
Palliative care should not be confused with hospice care. Palliative care teams should be involved early in the care of heart failure patients with the aims of improving symptom palliation, discussing goals of care and improving quality of life without compromising utilization of evidence-based heart failure therapies. A consensus on the appropriate timing of involvement and evidence for many symptom palliation therapies is still emerging.
KeywordsHeart failure Advanced heart failure Palliative care Goals of care
Compliance with Ethical Standards
Conflict of Interest
Abhinav Sood and Krista Dobbie each declare no potential conflicts of interest.
W.H. Wilson Tang is a section editor for Current Treatment Options in Cardiovascular Medicine.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
References and Recommended Reading
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 2.Haga K, Murray S, Reid J, Ness A, O’Donnell M, Yellowlees D, et al. Identifying community based chronic heart failure patients in the last year of life: a comparison of the gold standards framework prognostic indicator guide and the Seattle heart failure model. Heart. 2012;98(7):579–83.CrossRefPubMedGoogle Scholar
- 3.Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Jr., Colvin MM, et al. 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation. 2017.Google Scholar
- 6.Dunlay SM, Strand JJ, Wordingham SE, Stulak JM, Luckhardt AJ, Swetz KM. Dying with a left ventricular assist device as destination therapy. Circ Heart Fail. 2016;9(10).Google Scholar
- 7.•• Brannstrom M, Boman K. Effects of person-centred and integrated chronic heart failure and palliative home care. PREFER: a randomized controlled study. Eur J Heart Fail. 2014;16(10):1142–51.Randomized controlled trial showing the benefit of palliative care in improving quality of life and preventing rehospitalization when combined with usual care in advanced HF patients.Google Scholar
- 8.•• Rogers JG, Patel CB, Mentz RJ, Granger BB, Steinhauser KE, Fiuzat M, et al. Palliative care in heart failure: the PAL-HF randomized, controlled clinical trial. J Am Coll Cardiol. 2017;70(3):331–41.Randomized controlled clinical trial in Palliative medicine providing evidence for integration of palliative medicine in care of heart failure patients. Pall medicine combination with usual care resulted in improved quality of life and control of anxiety and depression.Google Scholar
- 11.Komajda M, Cowie MR, Tavazzi L, Ponikowski P, Anker SD, Filippatos GS. Physicians’ guideline adherence is associated with better prognosis in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry. Eur J Heart Fail. 2017;19(11):1414–23.CrossRefPubMedGoogle Scholar
- 17.• Vicent L, Nuñez Olarte JM, Puente-Maestu L, Oliva A, López JC, Postigo A, et al. Degree of dyspnoea at admission and discharge in patients with heart failure and respiratory diseases. BMC Palliat Care. 2017;16:35.Although a cross-sectional observational study, it indicates large proportion of patients with heart failure who continue to be symptomatic with severe dyspnea at the time of discharge and poor quality of life.Google Scholar
- 28.Ojero-Senard A, Benevent J, Bondon-Guitton E, Durrieu G, Chebane L, Araujo M, et al. A comparative study of QT prolongation with serotonin reuptake inhibitors. Psychopharmacology. 2017.Google Scholar
- 33.• Abernethy AP, McDonald CF, Frith PA, Clark K, Herndon JE, Marcello J, et al. Effect of palliative oxygen versus medical (room) air in relieving breathlessness in patients with refractory dyspnea: a double-blind randomized controlled trial. Lancet (Lond Engl). 2010;376(9743):784–93.Randomized clinical trial which showed no difference between room air and palliative oxygen for symptom control of breathlessness in refractory dyspnea in the absence of hypoxia. Alternative treatment strategies listed in the article should be tried for symptom relief.Google Scholar
- 34.Cranston JM, Crockett A, Currow D. Oxygen therapy for dyspnoea in adults. Cochrane Database Syst Rev. 2008(3):Cd004769.Google Scholar
- 36.• Sasayama S, Izumi T, Seino Y, Ueshima K, Asanoi H. Effects of nocturnal oxygen therapy on outcome measures in patients with chronic heart failure and cheyne-stokes respiration. Circ J. 2006;70(1):1–7.Randomized clinical trial providing evidence for improvement in quality of life with home nocturnal oxygen therapy, a non-pharmacologic intervention, in heart failure patients with Cheyne-Stokes breathing.Google Scholar
- 40.Hawker GA, Mian S, Kendzerska T, French M. Measures of adult pain: visual analog scale for pain (VAS Pain), numeric rating scale for pain (NRS Pain), McGill pain questionnaire (MPQ), short-form McGill pain questionnaire (SF-MPQ), chronic pain grade scale (CPGS), short form-36 bodily pain scale (SF-36 BPS), and measure of intermittent and constant osteoarthritis pain (ICOAP). Arthritis Care Res. 2011;63(S11):S240–S52.CrossRefGoogle Scholar
- 55.Rozentryt P, von Haehling S, Lainscak M, Nowak JU, Kalantar-Zadeh K, Polonski L, et al. The effects of a high-caloric protein-rich oral nutritional supplement in patients with chronic heart failure and cachexia on quality of life, body composition, and inflammation markers: a randomized, double-blind pilot study. J Cachexia Sarcopenia Muscle. 2010;1(1):35–42.CrossRefPubMedPubMedCentralGoogle Scholar
- 56.Dewey A, Baughan C, Dean T, Higgins B, Johnson I. Eicosapentaenoic acid (EPA, an omega-3 fatty acid from fish oils) for the treatment of cancer cachexia. Cochrane Database Syst Rev. 2007(1):Cd004597.Google Scholar
- 58.McKeag NA, McKinley MC, Harbinson MT, Noad RL, Dixon LH, McGinty A, et al. The effect of multiple micronutrient supplementation on left ventricular ejection fraction in patients with chronic stable heart failure: a randomized, placebo-controlled trial. JACC Heart Fail. 2014;2(3):308–17.CrossRefPubMedGoogle Scholar
- 64.• Moriarty AS, Gilbody S, McMillan D, Manea L. Screening and case finding for major depressive disorder using the Patient Health Questionnaire (PHQ-9): a meta-analysis. Gen Hosp Psychiatry. 2015;37(6):567–76.This meta-analysis provides high-grade evidence supporting the use of PHQ-9 for major depressive depression disorder screening and suggests a cutoff score of 10 as an acceptable screening cutoff.Google Scholar
- 66.• Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res. 1982;17(1):37–49.Validated scales to screen for depression in geriatric patients. Assumes importance because a significant proportion of patients with advanced HF are in the geriatric age group.Google Scholar
- 67.• Alexopoulos GS, Abrams RC, Young RC, Shamoian CA. Cornell scale for depression in dementia. Biol Psychiatry. 1988;23(3):271–84.Validated scales to screen for depression in patients with dementia. Assumes importance given the coexistence of dementia and heart failure.Google Scholar
- 68.O’Connor CM, Jiang W, Kuchibhatla M, Silva SG, Cuffe MS, Callwood DD, et al. Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (sertraline against depression and heart disease in chronic heart failure) trial. J Am Coll Cardiol. 2010;56(9):692–9.CrossRefPubMedPubMedCentralGoogle Scholar
- 78.Gandesbery B, Dobbie K, Gorodeski EZ. Outpatient palliative cardiology service embedded within a heart failure clinic: experiences with an emerging model of care. Am J Hospice Palliat Care 2017:1049909117729478.Google Scholar